Human Research Protection Program (HRPP)
DOMAIN I:
ORGANIZATION
Chapter
1: The Human Research Protection Program
The organizations (together referred to as “STANFORD”) covered by the Human Research Protection Program (HRPP) have a systematic and comprehensive program with appropriate leadership. (AAHRPP Standard I-1)
STANFORD* has a written plan for its HRPP appropriate for the volume and nature of the research involving human participants conducted under its auspices. (AAHRPP Element I.1.A)
The
1.1
Organizations Covered by the HRPP
The five STANFORD affiliated organizations are:
·
·
·
Lucile Packard
Children’s Hospital at Stanford (LPCH)
·
Veterans Affairs
·
Palo Alto
Institute for Research and Education (PAIRE).
Any components of these organizations as listed in their Federalwide Assurances (FWAs) are considered part of that organization for purposes of the HRPP and are covered by this HRPP Manual.
SHC and LPCH are
VAPAHCS is operated by
the US Department of Veterans Affairs to provide hospital, clinic and physician
services in the region of
1.2
Goal and
Objectives of the HRPP
The goal of the HRPP is to protect human research participants by
ensuring that in all STANFORD research:
Objectives of the HRPP
The HRPP includes mechanisms
to:
Written
Plan for the HRPP
The written plan for the HRPP is comprised of policies, guidances, and supporting documents governing human subject research and the protection of participants. The HRPP is approved by the Vice Provost and Dean of Research. The HRPP Manual is organized in 20 chapters, around the standards and elements of the Association for the Accreditation of Human Research Protection Programs (AAHRPP), with each chapter corresponding to one of the twenty standards of AAHRPP, as follows:
|
·
Organization |
·
Chapters 1 – 5 |
|
·
Research Review Unit, Including IRBs |
·
Chapters 6 – 13 |
|
·
Investigator |
·
Chapters 14 – 15 |
|
·
Sponsored Research |
·
Chapters 16 – 18 |
|
·
Participant Outreach |
·
Chapters 19 – 20 |
1.3 Delegation
of the Responsibility for HRPP Implementation to
STANFORD delegates
responsibility for the HRPP to the Vice Provost and Dean of Research,
For the organizations covered by the HRPP, the President of Stanford University delegates the primary responsibility to the Vice Provost and Dean of Research to establish, maintain, and oversee the HRPP. (See Delegation of Authority to Institutional Officer and Research Policy Handbook 7.0).
STANFORD considers the HRPP Manual to be a dynamic document, because the scientific developments, ethical issues, and regulatory circumstances that shape it are continuously evolving and improving. The Research Compliance Office (RCO) maintains policies and procedures reflecting the current practices of the IRB in conducting reviews and approvals of human research. As part of the RCO Continuous Quality Improvement (CQI) program, the RCO Director, in consultation with the HRPP Associate Director and the CQI Associate Director regularly reviews (i.e., at least annually) and refines the HRPP Manual and makes recommendations for modifications, or develops new policies and procedures as appropriate. The Vice Provost and Dean of Research may approve a modification of any portion of the HRPP Manual. The RCO Director may approve modifications to the HRPP Manual that relate to the day-to-day review and operational functions of the IRB; other modifications of the HRPP Manual must be approved by the Vice Provost and Dean of Research.
The RCO is responsible for disseminating all modifications to the HRPP Manual and incorporating them into the relevant educational programs (discussed in Chapter 4).
1.4
Research Covered by the HRPP
Types of human subject research at STANFORD
STANFORD conducts or oversees biomedical, social science and behavioral research. Human subject research is covered as stated in the Federalwide Assurance for each STANFORD affiliated organization. All research engaged in at STANFORD that involves human participants is covered by the HRPP.
An activity is covered by the HRPP when:
· It is considered “human subject research” - as defined in any one of the following:
- FDA regulations
- DHHS regulations or other Common Rule regulations
- VA regulations (VHA Handbook 1200.5 at http://www1.va.gov/visns/visn02/research/buf/f_/irb/guide/VHA_Handbook_1200_5_Protection_of_Human_Subjects.doc),
or
- Any other applicable state or local regulations, e.g.
and
·
STANFORD (or its employees or agents) is engaged
in the research – as defined by being involved in one or more of the following
activities:
- Receiving an HHS award for
research
- Intervening with
participants for research purposes (invasive or noninvasive)
- Manipulating the environment
- Interacting with
participants for research purposes
- Obtaining identifiable
private information or identifiable biological specimens from any source for
research purposes,
according to the OHRP guidance Engagement of
Institutions in Research at http://www.hhs.gov/ohrp/humansubjects/assurance/engage.htm.
Agents include all individuals performing institutionally designated activities or exercising institutionally delegated authority or responsibility, including students, faculty, staff, employees, visiting scholars.
See Chapter 3.3 for HRPP Manual policies and procedures for
determining when studies meet the regulatory definitions of human subject research.
Approvals Required Before Human Subject Research
Commences
IRB approval is required before research activities may commence.
In addition to approval from the IRB, depending on the funding source, either contract finalization or departmental approval is required before research involving human participants can commence, as follows:
· Externally funded research (industry-sponsored clinical trials and other clinical research) undergoes a parallel review process by a combination of the following, depending on the funding source:
- Research Management Group (RMG), who: develop and negotiate budget and payment schedules, route/ensure approvals,
- Office of Sponsored Research (OSR), who: negotiate terms and conditions, sign contracts, issue notices of award (NOA) for industry-sponsored clinical trials
- Industrial Contracts Office (ICO), who: handle Industry Research Agreements and Material Transfer Agreements (MTAs)
· Other research (see Chapter 1.7) requires approval by a Division Chief, Department Chair, School Dean or designee, or a faculty sponsor as appropriate, confirming:
- Scientific and scholarly validity
- Adequacy of resources.
Some protocol-specific situations require additional review and approval by other organizational components, or must meet their standards (see Chapter 2.4).
1.5
Primary Officials, Administrative
Units and Individuals of the HRPP
STANFORD Domain I: Officials Responsible for the HRPP
The primary responsibility for the HRPP lies with
Ann Arvin, M.D.: In 2006 President
John Hennessy appointed Ann Arvin, Lucile Salter
Packard Professor of Pediatrics and Professor of Microbiology/Immunology, to
the position of Vice
Provost and Dean of Research. In this position she serves on the
University's Executive Cabinet. Dr.
Arvin’s responsibilities and organization chart are given in
Administrative Guide Memo
12.11.
As
·
Creating, establishing and maintaining the
policies and procedures for the HRPP and related research policies and
procedures on behalf of
· Overseeing the protection of human participants, regulatory compliance, and the implementation of the HRPP for STANFORD
· Ensuring that open channels of communication are maintained between the components of the HRPP
· Overseeing research investigators and staff, and research management
· Ensuring the independence of the IRB, including the authority to act without undue influence
· Requiring periodic reviews of the HRPP
·
Ensuring that the HRPP is functional, adequately
staffed and funded, involving:
i). Annual review of the resources
allocated to the HRPP
ii).
Participation in the annual budget preparation for the HRPP and
incorporation of the HRPP budget into the
budget of
The day-to-day operational and oversight responsibility
for the HRPP is delegated to the Research
Compliance Director, a non-faculty, full-time administrator. The Research
Compliance Director reports to the Vice Provost and Dean of Research.
Kathy McClelland: The Research Compliance Office
(RCO) Director, Kathy McClelland, has day-to-day operational responsibility for
the HRPP through the RCO. She has over
25 years experience at Stanford dealing with aspects
of research integrity and compliance.
She has served as Director for the last twelve years. Before joining the Office of the Dean of
Research, she held positions in the
VAPAHCS Research and Development Committee: This committee is ultimately responsible for all human subject research which occurs at VAPAHCS. Its membership, functions and responsibilities are described in the VAPAHCS Health Care System Memorandum No. 151-05-08, Research and Development Committee and Associated Subcommittees.
STANFORD Domain II:
Research Review Unit, including IRBs
IRBs: The Administrative Panels on Human Subjects in Medical Research and the Administrative Panel on Human Subjects in Non-Medical Research are the Institutional Review Boards (IRBs) and perform many of the core functions of the HRPP. The Vice Provost and Dean of Research appoints the chairs and the members of the IRBs and assigns their authority and responsibility in the “charge” to the Chairs and members. See Charge to the Administrative Panel on Human Subjects in Medical Research by the Vice Provost and Dean of Research, and Charge to the Administrative Panel on Human Subjects in Non-Medical Research by the Vice Provost and Dean of Research. The charge emphasizes that the IRBs are functionally independent (e.g., of the individuals who are conducting the research) and have ready access to the highest officials of the covered organizations, if needed, to ensure protection for human research participants.
There are seven medical IRBs and one nonmedical IRB. Their authority, membership requirements, and
responsibilities are described in Chapter 6. IRBs are responsible for the initial and continuing
review, review of modifications, approval of all research subject to the HRPP, determining
serious or continuing noncompliance, requiring modification (to secure
approval), disapproving research, and applying applicable ethical standards.
IRB Staff in the Research Compliance Office: The HRPP Associate Director is responsible for supporting the daily operations of the IRBs. The IRB staff (Managers and Associates) review protocol applications for accuracy and completeness and act as liaisons between the Protocol Directors (PDs) and the IRB members. The IRB Training Specialist and the HRPP Education Specialist are responsible for the training of all individuals who are affected by the Human Research Protection Program. The Continuous Quality Improvement (CQI) Associate Director is responsible for the CQI plan and its implementation. This plan ensures periodic evaluation and strengthening of the HRPP.
Upon request, the RCO has responsibility for review and comment
on proposed external regulations dealing with human research. When appropriate, the RCO formulates and
recommends draft policies and procedures for approval by the appropriate
See Research Compliance Organization
Chart.
STANFORD Domain III: Investigator
Principal Investigator/Protocol
Director: The STANFORD
individual ultimately responsible for a protocol is the Protocol Director (PD). Most (but not all PDs) have faculty
appointments at
· All STANFORD human subject research has received initial prospective review and approval by the IRB.
· Continuing review and approval of the research has been accomplished within the time frame stipulated by the IRB.
· The research is conducted at all times in compliance with all applicable regulatory requirements and the determinations of the IRB.
Other Members of the Research Team: Every member
of the research team is responsible for protecting human participants. Co-investigators, study coordinators, nurses,
research assistants, faculty sponsors, student/staff investigators, and all other
research staff have the following strict obligations to:
· Comply with all IRB determinations and procedures
· Adhere rigorously to all protocol requirements
· Inform the PD, and thus IRB, of unanticipated problems
· Ensure the adequacy of the informed consent process
· Take necessary measures to ensure adequate protection for study
participants.
Responsibilities and
duties under the HRPP are described in more detail in Chapter 14
and Chapter 15.
STANFORD Domain IV: Sponsored Research
Sponsors can be a company, institution, individual donor or organization responsible for the initiation, management, or financing of a research study. Both the sponsor and STANFORD have obligations to protect research participants.
STANFORD Domain V: Participant Outreach
Participants in a research
project also have responsibilities.
These include telling the truth, asking for clarification, following the
protocol, notifying study personnel of their non-compliance, and telling investigators
if they wish to withdraw from the study.
HRPP
Organizational Components
In addition to the Vice
Provost and Dean of Research and the Research Compliance Office, human research
protection responsibilities are shared by these
Cancer
Clinical Trials Office (CCTO): The CCTO
provides
administrative, research, and educational services to
·
Facilitate
clinical trials and translational research by providing administrative support
to all
· Enhance and facilitate data collection and reporting of clinical cancer research